Eitan Rubin logo Ben-Gurion University of the Negev logo

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform


Dr. Rubin is a biologist, with a B.Sc from Ben-Gurion University in the Negev and a PhD from the Weizmann Institute of Science. Since 1992 he uses bioinformatics to analyze biological data with computational tools. Dr. Rubin previously worked in a bioinformatics company (Compugen) and managed two bioinformatics cores (at the Weizmann Institute of Science and Harvard University). Currently, his research focuses on advancing precision oncology through multi-dimensional analysis of advanced data sources (mostly NGS-derived), specializing in the application of modern data-sciences tools to understand the biology behind the differenital disease progression. Dr. Rubin works mostly in collaboration with experimental teams, both improving their ability to utilize experimental results as well as develop a hypothesis for further experimental investigation.

Dr. Rubin is a PI at Ben-Gurion University and the Head of the IT platform team of the WIN Consortium.


Why WIN

Cancer research has become the first line of Precision Medicine; WIN opens a way for me to become a part of a medical revolution.

Eitan Rubin logo

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform


Ben-Gurion University of the Negev logo

Dr. Rubin is a biologist, with a B.Sc from Ben-Gurion University in the Negev and a PhD from the Weizmann Institute of Science. Since 1992 he uses bioinformatics to analyze biological data with computational tools. Dr. Rubin previously worked in a bioinformatics company (Compugen) and managed two bioinformatics cores (at the Weizmann Institute of Science and Harvard University). Currently, his research focuses on advancing precision oncology through multi-dimensional analysis of advanced data sources (mostly NGS-derived), specializing in the application of modern data-sciences tools to understand the biology behind the differenital disease progression. Dr. Rubin works mostly in collaboration with experimental teams, both improving their ability to utilize experimental results as well as develop a hypothesis for further experimental investigation.

Dr. Rubin is a PI at Ben-Gurion University and the Head of the IT platform team of the WIN Consortium.


Why WIN

Cancer research has become the first line of Precision Medicine; WIN opens a way for me to become a part of a medical revolution.